Progressive MS Alliance Industry Forum: maximizing collective impact to enable drug development


In this month’s Trends in Pharmacological Sciences, the International Progressive MS Alliance has published a ‘white paper’ describing their ‘Industry Forum’, an innovative collaboration with Industry that is designed to drive a robust approach to developing new therapies for progressive forms of MS.

The Industry Forum is an advisory group to the Alliance made up of industry representatives who have personal knowledge and expertise in the development of new therapies. This expertise, combined with a governance structure under the leadership of global MS advocacy organizations, fosters collaboration while also ensuring a patient-centred approach to drug discovery and development.

The objective of the Industry Forum is to remove barriers and create an environment conducive to open discussions for drug discovery in progressive MS.

Drug discovery for progressive MS has been hampered by an incomplete understanding of the biological mechanisms that drive progression. The Alliance, by working with industry, aims to focus attention back onto the neuroprotective and neuroreparative strategies that are needed to target the ongoing neurodegenerative processes of progressive MS.

Through this open, collaborative approach they aim to open new avenues for drug development and ‘de-risk’ industry investment in progressive MS research.

View the white paper here:


Sign up to our e-newsletter
for updates from our growing global initiative to end progressive MS

Clicking submit confirms that you consent to MSIF sending you the Progressive MS Alliance newsletter

Please note, you must be aged 18 or older to subscribe to our newsletters.

Click here to read our Terms & Conditions and Privacy Policy